PatientMatch — Privacy-first clinical trial discovery

Showing 1–24 of 265 trials

Enrolling now

Nationwide

A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors

Columbia University

Lifestyle·~3yr·1 site in NY

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A First-in-Human Study of HLA-Partially to Fully Matched Allogeneic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

Ossium Health, Inc.

Ph 1/2·~2yr·9 sites in CA, FL, GA +5

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

ASTX030 Trial

Taiho Oncology, Inc.

Ph 2/3·~8yr·24 sites in CA, CT, FL +12

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase 1 Trial of Orca-Q

Orca Biosystems, Inc.

Ph 1·~9yr·9 sites in CA, FL, GA +4

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Phase 1/2 Trial of Bleximenib for Acute Leukemia

Janssen Research & Development, LLC

Ph 1/2·~7yr·27 sites in AZ, CA, IL +14

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies

Franziska Wachter

Ph 2·~6yr·2 sites in MA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia

St. Jude Children's Research Hospital

Ph 1·~5yr·1 site in TN

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

VA Office of Research and Development

Ph 2·~5yr·4 sites in CA, MO, NC +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center

Procedure·Ph 2·~2yr·7 sites in NJ, NY

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of BH-30236

BlossomHill Therapeutics

Ph 1·~3yr·13 sites in CA, FL, IL +6

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Edgewood Oncology Inc.

Ph 1·~7yr·3 sites in CA, NY, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of GLB-001

GluBio Therapeutics Inc.

Ph 1·~3yr·8 sites in CA, KS, NY +1

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of Nemtabrutinib Versus Comparator

Merck Sharp & Dohme LLC

Ph 3·~9yr·41 sites in AL, AZ, CA +19

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Loxo Oncology, Inc.

Ph 3·~6yr·19 sites in CA, FL, LA +8

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center

Ph 2·7 sites in NJ, NY

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study Comparing Chemotherapy to CPX-351 and/or Gilteritinib for Acute Myeloid Leukemia

Children's Oncology Group

Procedure·Ph 3·~9yr·185 sites in AL, AR, AZ +44

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

BeOne Medicines

Ph 3·~7yr·33 sites in CA, CO, CT +17

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Kura Oncology, Inc.

Ph 1·~7yr·44 sites in AZ, CA, CO +21

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia

City of Hope Medical Center

Ph 2·~2yr·1 site in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Baylor College of Medicine

Ph 1·~22yr·2 sites in TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Haploidentical Transplant Trial

University of Wisconsin, Madison

Procedure·Ph 1·~12yr·1 site in WI

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation

University of Florida

Device·Ph 2·~3yr·1 site in FL

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Autologous CD22 CAR T Cells Following Commercial CD19 CAR T Cells in B Cell Malignancies

Stanford University

Ph 1·~1.5yr·1 site in CA

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify

Nationwide

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

M.D. Anderson Cancer Center

Ph 2·~9yr·3 sites in MD, OH, TX

Enrolling now

Check if I qualify View study

Enrolling now

Check if I qualify